Ameritas Investment Partners’s Calithera Biosciences, Inc CALA Stock Holding History

Ameritas Investment Partners’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-291	Closed	-$14K	–	3320
2021 Q1	$14K	Hold	291	–	–	﹤0.01%	2731
2020 Q4	$29K	Hold	291	–	–	﹤0.01%	2301
2020 Q3	$20K	Hold	291	–	–	﹤0.01%	2390
2020 Q2	$31K	Buy	291 +88	+43%	+$10.5K	﹤0.01%	2120
2020 Q1	$18K	Hold	203	–	–	﹤0.01%	2247
2019 Q4	$23K	Buy	203 +69	+51%	+$5.19K	﹤0.01%	2361
2019 Q3	$8K	Hold	134	–	–	﹤0.01%	2830
2019 Q2	$10K	Hold	134	–	–	﹤0.01%	2815
2019 Q1	$18K	Hold	134	–	–	﹤0.01%	2442
2018 Q4	$11K	Hold	134	–	–	﹤0.01%	2646
2018 Q3	$14K	Hold	134	–	–	﹤0.01%	2709
2018 Q2	$13K	Hold	134	–	–	﹤0.01%	2757
2018 Q1	$17K	Hold	134	–	–	﹤0.01%	2508
2017 Q4	$22K	Hold	134	–	–	﹤0.01%	2392
2017 Q3	$44K	Hold	134	–	–	﹤0.01%	1976
2017 Q2	$40K	Buy	+134	New	+$35.8K	﹤0.01%	2060

Other funds holding CALA

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DMPV

Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameritas Investment Partners's CALA Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 291 shares — an estimated $14K sold.

Ameritas Investment Partners first reported a position in CALA in Q2 2017 and held it in 16 quarters. The position peaked at $44K in Q3 2017. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

Ameritas Investment Partners reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Partners sold 291 Calithera Biosciences, Inc shares in Q2 2021, an estimated $14K.
Ameritas Investment Partners first reported a position in Calithera Biosciences, Inc in Q2 2017 and held it in 16 quarters.
Ameritas Investment Partners's Calithera Biosciences, Inc position peaked at $44K in Q3 2017.
76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.